Delivery Order SPE2DB24D9802-SPE2DB25FJKYN

Award Date 6/12/25
Potential Completion Date 6/13/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, with a ceiling value of $2,265.00 and an ultimate completion date of May 22, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $4,354.20, is for the delivery of 4,568,168,531 units of NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The contract has an ultimate completion date of May 5, 2025 and was awarded on May 2, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, holding a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,020.72 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of 4563902919 NOVOLOG MIX 70-30 FLEXPEN 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA, contract number 4600082013 under the SPE2DB program, valued at up to $4,999,999 through 2025. The IDC enables DLA to issue delivery orders for a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the supply of NOVOLOG PENFILL 100 UNIT/ML 3ML, a pharmaceutical product, with a ceiling value of $2,338.00 and a performance period through May 22, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,436.52 contract is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a diabetes medication. The award has an ultimate completion date of May 1, 2025 and was made on April 30, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The contract has a firm fixed price of $1,349.19 and a period of performance through December 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $25,944.20 firm fixed-price contract is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product, with a performance period through May 14, 2025. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, under the SPE2DB program. This IDC enables the DLA to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,903.37 firm fixed-price contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has an ultimate completion date of March 19, 2025 and was awarded on March 18, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the prime contractor, to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceuticals. The award has a potential value of $1,225.44 and a completion date of February 5, 2024. This delivery order is placed under an Indefinite Delivery Contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to...
This is a $5,374.01 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The contract has a period of performance through July 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of essential...
  • SPE2DB24D9802
    Indefinite Delivery Contract
  • SPE2DB24D9802-SPE2DB25FJKYN
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, with a ceiling value of $3,020.00 and an ultimate completion date of June 13, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 9/11/25, 11:05 AM